These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17136660)

  • 41. [Immunosuppression trials in type I diabetes].
    Feutren G; Boitard C; Assan R; Bach JF
    Journ Annu Diabetol Hotel Dieu; 1987; ():147-69. PubMed ID: 3302472
    [No Abstract]   [Full Text] [Related]  

  • 42. [The role of inhibitors of the complement activation system in the pathogenesis and therapy of insulin-dependent diabetes mellitus (review)].
    Aleksandrovskiĭ IaA
    Vopr Med Khim; 1988; 34(3):7-15. PubMed ID: 3047972
    [No Abstract]   [Full Text] [Related]  

  • 43. Editorial Comment on type 1 diabetes and antigen-specific immunotherapy.
    Lernmark Å; Larsson HE
    J Intern Med; 2011 Aug; 270(2):132-5. PubMed ID: 21668820
    [No Abstract]   [Full Text] [Related]  

  • 44. Efforts to prevent and halt autoimmune beta cell destruction.
    Haller MJ; Atkinson MA; Schatz DA
    Endocrinol Metab Clin North Am; 2010 Sep; 39(3):527-39. PubMed ID: 20723818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diabetes associated with infection].
    Kobayashi T; Harii N
    Nihon Rinsho; 2006 Sep; Suppl 3():86-9. PubMed ID: 17022506
    [No Abstract]   [Full Text] [Related]  

  • 46. Beta-cell replacement for insulin-dependent diabetes mellitus.
    Efrat S
    Adv Drug Deliv Rev; 2008 Jan; 60(2):114-23. PubMed ID: 18022276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 Diabetes.
    Anquetil F; Mondanelli G; Gonzalez N; Rodriguez Calvo T; Zapardiel Gonzalo J; Krogvold L; Dahl-Jørgensen K; Van den Eynde B; Orabona C; Grohmann U; von Herrath MG
    Diabetes; 2018 Sep; 67(9):1858-1866. PubMed ID: 29945890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. beta-Cells step up in controlling the autoimmune response.
    Fiorina P
    Diabetes; 2010 Aug; 59(8):1861-4. PubMed ID: 20668291
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunology of type 1 diabetes.
    Narendran P; Estella E; Fourlanos S
    QJM; 2005 Aug; 98(8):547-56. PubMed ID: 15955793
    [No Abstract]   [Full Text] [Related]  

  • 50. Controversies in medicine: redefining the diagnosis of type 1 diabetes.
    Couper JJ; Harrison LC
    Med J Aust; 2019 Aug; 211(4):157-159.e1. PubMed ID: 31318055
    [No Abstract]   [Full Text] [Related]  

  • 51. [Is diabetes mellitus, type I an autoimmune disease and can we prevent its onset?].
    Knip M
    Duodecim; 2004; 120(9):1158-65. PubMed ID: 15232859
    [No Abstract]   [Full Text] [Related]  

  • 52. [Immunotherapy in type 1 (insulin-dependent) diabetes].
    Galluzzo A
    Recenti Prog Med; 1984 Oct; 75(10):936-43. PubMed ID: 6083588
    [No Abstract]   [Full Text] [Related]  

  • 53. Pancreatic pathology in type 1 diabetes in human.
    Foulis AK
    Novartis Found Symp; 2008; 292():2-13; discussion 13-8, 122-9, 202-3. PubMed ID: 19203089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine and immunosuppressive therapies of type 1 diabetes mellitus.
    Gottlieb PA; Hayward AR
    Endocrinol Metab Clin North Am; 2002 Jun; 31(2):477-95. PubMed ID: 12092462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes.
    Jinnouchi Y; Yamagishi S; Takeuchi M; Ishida S; Jinnouchi Y; Jinnouchi J; Imaizumi T
    Clin Exp Med; 2006 Dec; 6(4):191-3. PubMed ID: 17191111
    [No Abstract]   [Full Text] [Related]  

  • 56. [Etiology of insulin-dependent diabetes. Prospects for immunological therapy].
    Levy-Marchal C; Czernichow P
    Ann Pediatr (Paris); 1986 Dec; 33(10):877-81. PubMed ID: 3827098
    [No Abstract]   [Full Text] [Related]  

  • 57. Type 1 diabetes: lessons for other autoimmune diseases?
    Harrison LC; Honeyman MC; Morahan G; Wentworth JM; Elkassaby S; Colman PG; Fourlanos S
    J Autoimmun; 2008 Nov; 31(3):306-10. PubMed ID: 18558477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Path to Insulin Independence: "The End of the Beginning".
    Stock PG; German MS
    Cell Stem Cell; 2016 Apr; 18(4):431-3. PubMed ID: 27058933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapies aimed at preservation or restoration of beta cell function in type 1 diabetes.
    Keymeulen B
    Verh K Acad Geneeskd Belg; 2008; 70(2):85-103. PubMed ID: 18630722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of a cocktail regimen consisting of soluble galectin-1, rapamycin and histone deacetylase inhibitor may effectively prevent type 1 diabetes.
    Jiang GX; Cui YF; Zhong XY; Tai S; Liu W; Wang ZD; Shi YG
    Arch Med Res; 2009 Jul; 40(5):424-6. PubMed ID: 19766909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.